Oliver Lagore Vanvalin Investment Group Edwards Lifesciences Corp Transaction History
Oliver Lagore Vanvalin Investment Group
- $370 Million
- Q4 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 1,490 shares of EW stock, worth $107,995. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,490
Previous 1,490
-0.0%
Holding current value
$107,995
Previous $98,000
12.24%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding EW
# of Institutions
1,384Shares Held
454MCall Options Held
6.71MPut Options Held
3.17M-
Vanguard Group Inc Valley Forge, PA69.1MShares$5.01 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.69 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.87 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY14.9MShares$1.08 Billion0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA13.6MShares$989 Million0.08% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $44.8B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...